相关实验视频
Updated: Sep 12, 2025

04:41
Knee Arthrocentesis in Adults
Published on: February 25, 2022
7.9K
局部与系统性特兰胺酸相比,以减少膝盖和关节整形术后的血液损失:系统性审查和元分析
Maude Boucher1, Juliette Tremblay1, Théo Pelet1
1Faculty of Medicine, Université Laval, Quebec City, Quebec, Canada.
The Journal of bone and joint surgery. American volume
|August 5, 2025
概括
局部和全身特兰胺酸 (TXA) 在减少关节和膝关节置换期间的血液损失方面表现出类似的有效性. 然而,局部TXA在膝盖手术中更有效,而全身TXA在部手术中更有效.
科学领域:
- 整形外科手术 整形外科手术
- 药理学 药理学是指药理学的学科.
- 基于证据的医学基于证据的医学.
背景情况:
- 特兰胺酸 (TXA) 用于减少在全膝关节整形术 (TKA) 和全关节整形术 (THA) 中的血液损失.
- 最佳的TXA施用方法 (局部或全身) 尚不清楚.
研究的目的:
- 为了比较局部与全身三胺酸 (TXA) 在减少手术流失的疗效.
- 评估二次结果,包括输血需求,血红蛋白水平,住院和不良事件.
主要方法:
- 随机对照试验 (RCT) 的系统审查和元分析.
- 在MEDLINE,Embase和Cochrane CENTRAL搜索相关研究.
- 包括选择性TKA和THA患者,比较局部和全身TXA给药.
主要成果:
- 当结合TKA和THA时,局部和全身TXA之间的血液损失没有显著差异 (Hedges g = 0.11).
- 亚组分析显示,局部TXA显著减少了TKA的血液损失 (g = 0.19),而系统TXA在THA中更有效.
- 在血红蛋白下降,输血需求或住院时间方面没有观察到显著差异.
结论:
- 当TKA和THA一起分析时,局部和系统TXA同样有效.
- 局部TXA在TKA中显示出优异的降低血液损失,而系统TXA在THA中更有效.
- 需要进一步的研究来确定最佳的TXA剂量和给药途径.
更多相关视频
相关概念视频
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Anticoagulant Drugs: Low-Molecular-Weight Heparins
909
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
909
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K

